Coeptis Therapeutics Stock (NASDAQ: COEP) stock price, news, charts, stock research, profile.
You can purchase shares of Coeptis Therapeutics (NASDAQ:COEP) through any online brokerage.
Other companies in Coeptis Therapeutics’s space includes: Vincerx Pharma (NASDAQ:VINC), Syros Pharmaceuticals (NASDAQ:SYRS), Alzamend Neuro (NASDAQ:ALZN), Galecto (NASDAQ:GLTO) and T2 Biosystems (NASDAQ:TTOO).
Coeptis Therapeutics has a consensus price target of $5.67.
The stock price for Coeptis Therapeutics (NASDAQ: COEP) is $0.142 last updated December 20, 2024 at 6:56 PM EST.
There are no upcoming dividends for Coeptis Therapeutics.
Coeptis Therapeutics’s Q3 earnings are confirmed for Wednesday, November 13, 2024.
There is no upcoming split for Coeptis Therapeutics.
Coeptis Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.